Deleted Tweets From Scott Gottlieb, R-D.C.

RT @Surgeon_General: "Addiction is also personal to me. My brother has struggled w/addiction for years & like many others in his predica… https://t.co/Mbd03ccuWN

RT @AlecGaffney: The FDA is launching a new program to expedite orphan drug requests. Some nice details from @ZacharyBrennan here:… https://t.co/ZnzcVvawzE

RT @Surgeon_General: "I want people to know that prevention works, treatment is effective and people recover every day. Together, we ca… https://t.co/L9R9lZaM49

RT @FDATobacco: More than 150,000 people die each year from cardiovascular diseases caused by cigarette smoking. Learn more… https://t.co/yV6xs6yWin

RT @dgingery: Still more Wednesday reading: US #FDA/NORD Partnership Will Further Increase Patient Involvement In Drug Development https://t.co/BzAv1GiXq4

RT @US_FDA: Looking for more information on approved biological products, including biosimilars? Check out the FDA Purple Book.… https://t.co/CK7nc1zqQZ

RT @AP_FDAwriter: FDA sent letters yesterday to Wal-Mart, Amazon, e-bay and Jet asking them not to sell Imodium and related diarrhea… https://t.co/Taqn7lJUi5

RT @FDAMedia: Statement from @SGottliebFDA on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts la… https://t.co/CguV7LZs66

Today, under the Mutual Recognition Agreement, #FDA notified 4 countries (Czech Republic, Greece, Hungary & Romania) that they are recognized, based on quality, of being able to conduct inspections of manufacturing facilities that meet FDA requirement

RT @RonPiervincenzi: We are @USPharmacopeia congratulate OPQ on its important achievements and strong leadership over the past year, and lo… QT @SGottliebFDA: The Office of Pharmaceutical Quality has facilitated pharmaceutical tech advancements, like 3D printing and continu… https://t.co/y3F7atvmFq)

#FDA is learning about the potential root cause for why this year’s #flu vaccine showed diminished efficacy against the season’s predominant H3N2 strain of influenza and applying those lessons for the future https://t.co/NNpr8eBO1l

#FDA’s Vaccines and Related Biological Products Advisory Committee is meeting today to make recommendations for strain selections for next year’s flu vaccines. Watch the live webcast: https://t.co/Xzfsyz6vqE

Today, we sent letters to several retailers asking that they take important steps to help address growing problem of abuse/misuse of over-the-counter loperamide. This follows January’s request that makers of OTC loperamide limit the number of doses in a p

The benefit of the Mutual Recognition Agreement is that we can create greater efficiencies and better fulfill our public health goals, by relying on inspectional expertise of our colleagues and refocusing resources on inspections in higher risk countries

RT @EMA_News: 4 more #EU Member States benefit from EU-US mutual recognition agreement for inspections: https://t.co/rExR6bNjwE #GMP @US_FDA @EU_Health

Our letters to retailers re: OTC loperamide requests they: 1) Not sell bundled amounts that contain more than one package of the drug & 2) Ensure consumers can easily access/read the Drug Facts Label so consumers can read warnings about risks of high

Retailers sell OTC loperamide in large, bundled amounts ‒ sometimes w/up to 1,200 tablets avail in single purchase. If retailers continue to sell in this way, it will undermine other steps being taken to curb dangerous abuse/misuse outlined in January: ht

As we noted in Jan., at higher than recommended doses of loperamide, we’ve received reports of serious heart problems/deaths, particularly among people who are misusing and abusing to manage opioid withdrawal symptoms or achieve euphoric effects: https://

#FDA recognizes the important role that the retailers receiving letters from us today play in helping deliver safe and effective OTC drugs to consumers. We thank them in advance for their efforts to address the serious public health issue related to OTC l

My statement on #FDA’s new efforts to advance implementation of the consumer Nutrition Facts label for foods: https://t.co/R9fzEsf8nP

RT @Surgeon_General: "Addiction is also personal to me. My brother has struggled w/addiction for years & like many others in his predica… https://t.co/Mbd03ccuWN

RT @AlecGaffney: The FDA is launching a new program to expedite orphan drug requests. Some nice details from @ZacharyBrennan here:… https://t.co/ZnzcVvawzE

RT @Surgeon_General: "I want people to know that prevention works, treatment is effective and people recover every day. Together, we ca… https://t.co/L9R9lZaM49

RT @FDATobacco: More than 150,000 people die each year from cardiovascular diseases caused by cigarette smoking. Learn more… https://t.co/yV6xs6yWin

RT @dgingery: Still more Wednesday reading: US #FDA/NORD Partnership Will Further Increase Patient Involvement In Drug Development https://t.co/BzAv1GiXq4

RT @US_FDA: Looking for more information on approved biological products, including biosimilars? Check out the FDA Purple Book.… https://t.co/CK7nc1zqQZ

RT @AP_FDAwriter: FDA sent letters yesterday to Wal-Mart, Amazon, e-bay and Jet asking them not to sell Imodium and related diarrhea… https://t.co/Taqn7lJUi5

RT @FDAMedia: Statement from @SGottliebFDA on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts la… https://t.co/CguV7LZs66

Today, under the Mutual Recognition Agreement, #FDA notified 4 countries (Czech Republic, Greece, Hungary & Romania) that they are recognized, based on quality, of being able to conduct inspections of manufacturing facilities that meet FDA requirement

RT @RonPiervincenzi: We are @USPharmacopeia congratulate OPQ on its important achievements and strong leadership over the past year, and lo… QT @SGottliebFDA: The Office of Pharmaceutical Quality has facilitated pharmaceutical tech advancements, like 3D printing and continu… https://t.co/y3F7atvmFq)

#FDA is learning about the potential root cause for why this year’s #flu vaccine showed diminished efficacy against the season’s predominant H3N2 strain of influenza and applying those lessons for the future https://t.co/NNpr8eBO1l

#FDA’s Vaccines and Related Biological Products Advisory Committee is meeting today to make recommendations for strain selections for next year’s flu vaccines. Watch the live webcast: https://t.co/Xzfsyz6vqE

Today, we sent letters to several retailers asking that they take important steps to help address growing problem of abuse/misuse of over-the-counter loperamide. This follows January’s request that makers of OTC loperamide limit the number of doses in a p

The benefit of the Mutual Recognition Agreement is that we can create greater efficiencies and better fulfill our public health goals, by relying on inspectional expertise of our colleagues and refocusing resources on inspections in higher risk countries

RT @EMA_News: 4 more #EU Member States benefit from EU-US mutual recognition agreement for inspections: https://t.co/rExR6bNjwE #GMP @US_FDA @EU_Health

Our letters to retailers re: OTC loperamide requests they: 1) Not sell bundled amounts that contain more than one package of the drug & 2) Ensure consumers can easily access/read the Drug Facts Label so consumers can read warnings about risks of high

Retailers sell OTC loperamide in large, bundled amounts ‒ sometimes w/up to 1,200 tablets avail in single purchase. If retailers continue to sell in this way, it will undermine other steps being taken to curb dangerous abuse/misuse outlined in January: ht

As we noted in Jan., at higher than recommended doses of loperamide, we’ve received reports of serious heart problems/deaths, particularly among people who are misusing and abusing to manage opioid withdrawal symptoms or achieve euphoric effects: https://

#FDA recognizes the important role that the retailers receiving letters from us today play in helping deliver safe and effective OTC drugs to consumers. We thank them in advance for their efforts to address the serious public health issue related to OTC l

My statement on #FDA’s new efforts to advance implementation of the consumer Nutrition Facts label for foods: https://t.co/R9fzEsf8nP